Progress, Potential, and Possibilities Podcast / Show · 2026-05-01 · 35 min
Send us Fan Mail Imagine a device that can sense disease in real time… and treat it instantly. That’s the promise of Bioelectronics. Dr. Robert Spoelgen, Ph.D. is Vice President and Head of Bioelectronics at Merck KGaA Darmstadt Germany ( ), where he leads one of the company’s most forward-looking initiatives at the intersection of neuroscience, medical devices, and digital health. In this role, he founded and now drives Merck KGaA Darmstadt Germany’s bioelectronics strategy, focused on developing implantable neurostimulation technologies - particularly selective peripheral nerve stimulation platforms - to treat chronic diseases and enable real-time patient monitoring. Dr. Spoelgen’s work reflects a broader shift within pharma toward “beyond the pill” modalities, combining device-based therapies with data-driven insights. His team collaborates with medtech partners to develop precision neuromodulation approaches, including vagus nerve stimulation platforms aimed at conditions ranging from hypertension to inflammatory disease. Before launching bioelectronics at Merck KGaA Darmstadt Germany, Dr.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Disrupting Airlines, Streaming, and Healthcare for GoodThe Shift Code · on digital health79 / 100
Neuroscience Tools For Leadership and Change with Dr. Lisa RiegelThe Talent Forge · on Vagus nerve79 / 100
Niterra VenturesImpacTV · on digital health74 / 100
Derek Baird from Switchboard HealthProduct in Healthtech · on digital health68 / 100
077: How To Be Remarkable Under High Stress with Leigh AndersonThe Remarkable Project · on Vagus nerve65 / 100
Building Resilience In a Tough Sales World | Mark Divine - 2014The Sales Evangelist · on Vagus nerve64 / 100Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 10055 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100How Regenerative Medicine Is Reinventing Breast Reconstruction | Dr. Claudia Chavez-Munoz, MD, PhD - Chief Scientific Officer and Co-Founder - Conexeu Sciences